Trial intelligence / Profile preview

TG100-115 in Acute Anterior STEMI Undergoing PCI

NCT00103350Phase 2Completed

Sponsor
TargeGen, Inc.
Start
Jan 2005
Primary completion
Dec 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of TG100-115 in Acute anterior ST-segment elevation myocardial infarction, sponsored by TargeGen, Inc.. Started Jan 2005; status: completed.

02

Drugs

TG100-115
03

Conditions

Acute anterior ST-segment elevation myocardial infarction

Beyond the preview

Go deeper on NCT00103350.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00103350.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call